Overview

Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This is a Phase II clinical trial evaluating the benefit from therapy with vintafolide in participants with progressive adenocarcinoma of the lung.
Phase:
Phase 2
Details
Lead Sponsor:
Endocyte
Treatments:
Folic Acid
Vinca Alkaloids